Department of Neurology, Haukeland University Hospital, Bergen, Norway.
J Neuroimmunol. 2011 Mar;232(1-2):166-70. doi: 10.1016/j.jneuroim.2010.10.009. Epub 2010 Nov 19.
Onconeural antibodies are found in many patients with paraneoplastic neurological syndromes (PNS) and define the disease as paraneoplastic. The study describes the presence of onconeural antibodies and PNS in 555 patients with neurological symptoms and confirmed cancer within five years, and compares the diagnostic accuracy of different antibody assays (immunoprecipitation, immunofluorescence and immunoblot). Onconeural antibodies were found in 11.9% of the patients by immunoprecipitation, in 7.0% by immunofluorescence and in 6.3% by immunoblot. PNS were present in 81.8% of the cancer patients that were seropositive by immunoprecipitation. Immunofluorescence and immunoblot failed to detect onconeural antibodies in almost one third of the PNS cases.
在许多副肿瘤性神经综合征 (PNS) 患者中可发现肿瘤相关抗体,并将该疾病定义为副肿瘤性。本研究描述了在 555 例五年内确诊癌症且伴有神经系统症状的患者中存在肿瘤相关抗体和 PNS,并比较了不同抗体检测方法(免疫沉淀、免疫荧光和免疫印迹)的诊断准确性。免疫沉淀法发现 11.9%的患者存在肿瘤相关抗体,免疫荧光法发现 7.0%的患者存在肿瘤相关抗体,免疫印迹法发现 6.3%的患者存在肿瘤相关抗体。免疫沉淀法阳性的癌症患者中,81.8%存在 PNS。免疫荧光法和免疫印迹法几乎未能检测到三分之一的 PNS 患者的肿瘤相关抗体。